Market Currents
Optimer Pharmaceuticals (OPTR): Q4 EPS of $0.29 may not be comparable to consensus of $0.51....
-
Wednesday, March 7, 2012, 5:25 PM ETOptimer Pharmaceuticals (OPTR): Q4 EPS of $0.29 may not be comparable to consensus of $0.51. Revenue of $64.6M beats by $21M. Shares +0.9% AH. (PR)
Other date
Latest Earnings Articles
